Znanstveni rad - Izvorni znanstveni rad
Higher estimated plasma volume status is associated with increased thrombotic risk and impaired survival in patients with primary myelofibrosis
Biochemia Medica, 33 (2023), 2; 020901. https://doi.org/10.11613/BM.2023.020901

Lucijanić, Marko; Krečak, Ivan; Sorić, Ena; Sabljić, Anica; Galušić, Davor; Holik, Hrvoje; Periša, Vlatka; Perić, Martina Morić; Zekanović, Ivan; Kušec, Rajko

Citirajte ovaj rad

Lucijanić, M., Krečak, I., Sorić, E., Sabljić, A., Galušić, D., Holik, H. ... Kušec, R. (2023). Higher estimated plasma volume status is associated with increased thrombotic risk and impaired survival in patients with primary myelofibrosis. Biochemia Medica, 33. (2). doi: 10.11613/BM.2023.020901

Lucijanić, Marko, et al. "Higher estimated plasma volume status is associated with increased thrombotic risk and impaired survival in patients with primary myelofibrosis." Biochemia Medica, vol. 33, br. 2, 2023. https://doi.org/10.11613/BM.2023.020901

Lucijanić, Marko, Ivan Krečak, Ena Sorić, Anica Sabljić, Davor Galušić, Hrvoje Holik, Vlatka Periša, Martina Morić Perić, Ivan Zekanović i Rajko Kušec. "Higher estimated plasma volume status is associated with increased thrombotic risk and impaired survival in patients with primary myelofibrosis." Biochemia Medica 33, br. 2 (2023). https://doi.org/10.11613/BM.2023.020901

Lucijanić, M., et al. (2023) 'Higher estimated plasma volume status is associated with increased thrombotic risk and impaired survival in patients with primary myelofibrosis', Biochemia Medica, 33(2). doi: 10.11613/BM.2023.020901

Lucijanić M, Krečak I, Sorić E, Sabljić A, Galušić D, Holik H, i sur.. Higher estimated plasma volume status is associated with increased thrombotic risk and impaired survival in patients with primary myelofibrosis. Biochemia Medica [Internet]. 2023. [pristupljeno 10.07.2024.];33(2). doi: 10.11613/BM.2023.020901

M. Lucijanić, et al., "Higher estimated plasma volume status is associated with increased thrombotic risk and impaired survival in patients with primary myelofibrosis", Biochemia Medica, vol. 33, br. 2, 2023. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:721932. [Citirano: 10.07.2024.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.